Regulation

Jay Rughani, investment partner at a16z, discusses 2023 events, predictions for digital health funding in 2024 and proper AI regulation to avoid stifling innovation.

Boston Children’s, CVS, Geisinger, UC San Diego and Wellspan are among the 28 providers and payers promising their AI and machine learning models are geared to ensure healthcare outcomes that are "Fair, Appropriate, Valid, Effective and Safe."  

The kit was determined to be comparable to a device used in clinically-administered intrauterine insemination.

Dr. Michael Howell, chief clinical officer at Google, discusses Med-PaLM's evolution in 2023 and recommendations for regulators developing rules for AI use in healthcare.

The AI-enabled hearing aids automatically adjust to an individual's hearing needs without configuration.

The White House plan for "safe, secure and trustworthy" artificial intelligence wants the Department of Health and Human Services to have a mechanism in place to collect reports of "harms or unsafe healthcare practices," and act to remedy them.  

The FDA clarifies its interpretation of "more effective," and indicates it will consider improved accessibility of a device during the Breakthrough designation process.

The smartphone-sized device offers continuous monitoring of respiration rate while allowing patient mobility.

The agencies contacted 130 health systems and telehealth providers by mail to emphasize the potential HIPAA risks of using Meta/Facebook pixel and Google Analytics tracking tools that may be "impermissibly disclosing" protected health information.  

The Ohio-based company's XR90 offering allows physicians to view a patient's anatomical structures in 3D for preoperative and intraoperative use.